In vitro cell cultures of Brunner's glands from male mouse to study GLP-1 receptor function.


Journal

American journal of physiology. Cell physiology
ISSN: 1522-1563
Titre abrégé: Am J Physiol Cell Physiol
Pays: United States
ID NLM: 100901225

Informations de publication

Date de publication:
01 06 2022
Historique:
pubmed: 21 4 2022
medline: 9 6 2022
entrez: 20 4 2022
Statut: ppublish

Résumé

Exocrine glands in the submucosa of the proximal duodenum secrete alkaline fluid containing mucus to protect the intestinal mucosa from acidic stomach contents. These glands, known as Brunner's glands, express high glucagon-like peptide 1 receptor (GLP-1R) levels. Previous studies have suggested that activation of the GLP-1R induces expression of barrier protective genes in Brunner's glands. Still, the lack of a viable in vitro culture of Brunner's glands has hampered additional studies of the functional consequences of GLP-1R activation. In this study, we established a procedure to isolate and culture cells derived from murine Brunner's glands. The isolated glandular cells retained functional GLP-1R expression in culture, making this in vitro system suitable for the study of GLP-1R activation. We found that cells derived from the Brunner's glands of mice pretreated with semaglutide contained significantly more mucus compared with Brunner's glands from vehicle-treated mice. Our data suggest a protective intestinal response upon semaglutide treatment, but further studies are required to leverage the full potential of cultured Brunner's gland cells.

Identifiants

pubmed: 35442827
doi: 10.1152/ajpcell.00345.2021
doi:

Substances chimiques

GLP1R protein, human 0
Glucagon-Like Peptide-1 Receptor 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

C1260-C1269

Auteurs

Louise M Voetmann (LM)

Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg, Denmark.
Global Drug Discovery, Novo Nordisk A/S, Måløv, Denmark.

Christina R Underwood (CR)

Global Drug Discovery, Novo Nordisk A/S, Måløv, Denmark.

Bidda Rolin (B)

Global Drug Discovery, Novo Nordisk A/S, Måløv, Denmark.

Axel K Hansen (AK)

Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg, Denmark.

Rikke K Kirk (RK)

Global Drug Discovery, Novo Nordisk A/S, Måløv, Denmark.

Charles Pyke (C)

Global Drug Discovery, Novo Nordisk A/S, Måløv, Denmark.

Lotte B Knudsen (LB)

Global Drug Discovery, Novo Nordisk A/S, Måløv, Denmark.

Klaus S Frederiksen (KS)

Global Drug Discovery, Novo Nordisk A/S, Måløv, Denmark.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH